Sitemap

Pages

• 545600
• Accessibility
• Cookies
• Disclaimer
• Homepage
• Homepage German
• Information
• Nachrichten
• News
• Privacy Policy
• Sitemap
• Terms and Conditions
• About Us
  • Company
  • Quality & Regulatory
  • Innovation
  • Careers
  • Sealantis
  • Biomatlante
• Job listings
• Our Brands
  • LiquiBand®
  • ActivHeal®
  • RESORBA®
• Our Services
  • Symbols Glossary
• Our Divisions
  • Surgical
    • LiquiBand®
    • RESORBA®
    • Partners
    • Request Information
  • Woundcare
    • ActivHeal®
    • Foams
    • Hydrogels
    • Film
    • Hydrocolloids
    • Alginates
    • Request Information
    • Downloads
• Our Technologies
  • Alginates
  • Collagen
  • Cyanoacrylates
  • Foam
  • Hydrocolloid
  • Hydrogels
  • Internal Sealants
  • Oxidised Cellulose
  • Sutures
• RESORBA®
• Corporate Responsibility
• Investor Relations
  • At a Glance
  • Financial Highlights
  • Our Business
    • Our Investment Case
    • Our Mission and Strategy
    • Our Business Model
    • Environmental, Social and Governance
  • Corporate Governance
    • Corporate Governance
    • Statement of Compliance
    • Stakeholder Engagement (s172)
    • Board of Directors
    • Board Committees
      • Audit Committee
      • Nomination Committee
      • Remuneration Committee
    • Directors’ Responsibilities
    • Key Performance Indicators
    • Senior Management
  • Shareholder Information
    • AGM
    • AIM Rule 26 Information
    • Warning to Shareholders
    • Shareholder Analysis
    • Financial Calendar
    • Company Documents
    • Advisors
    • Analysts
  • Share Price Information
    • Shareholder Price Data
    • Share Price Calculator
    • Glossary of Share Price Terms
  • Regulatory News (RNS)
  • Financial Reports & Results
    • Annual / Interim Reports
    • Results & Presentations
  • FAQs
  • RNS Alert Service
• Contact
  • Our Locations
  • Make an Enquiry
• Why invest in AMS
• Application

Posts

• Advanced Medical Solutions announces its unaudited preliminary results for the year ended 31 December 2022
• Advanced Medical Solutions announces the acquisition of Connexicon Medical Limited
• Advanced Medical Solutions announces its unaudited interim results for the six months ended 30 June 2022
• Advanced Medical Solutions announces the posting of the Annual Report and Accounts for the year ended 31 December 2021
• Advanced Medical Solutions announces its unaudited preliminary results for the year ended 31 December 2021
• Advanced Medical Solutions announces its unaudited interim results for the six months ended 30 June 2021
• Acquisition of Raleigh Coatings, a woundcare and bio-diagnostics coatings business
• Acquisition of Biomatlante, a developer and manufacturer of innovative surgical biomaterial technologies
• Stifel UK Healthcare Seminar
• Best Ideas Conference 2019
• Jefferies 2019 London Healthcare Conference – November 20 2019
• Acquisition of Sealantis
• Jefferies 2018 London Healthcare Conference – November 14-15 2018
• Authorised Economic Operator (AEO)
• AMS wins Medilink North West Partnership with the NHS award 2016
• AMS wins Bionow Product of the Year Award 2015
• Advanced Medical Solutions sponsors the 2015 Cheshire Classic
• Acquisition of RESORBA®
• Wound Care Education Programme
• Development and Pre-Supply Agreement signed with Surgical Innovations Group plc
• World leading wound care and wound closure range showcased at Arab Health 2010
• AMS Wins BioMedical Company of the Year Award
• AMS Acquisition of Corpura B.V.
• AMS Show Case Advance Wound Care and Wound Closure Products at Hospitalar 2009
• LiquiBand Optima – Skin Adhesive – Wins Medical Design Excellence Award
• World leading wound care and wound closure range showcased at Arab Health 2009
• Faster, Stronger, Safer and More Precise Wound Closure with LiquiBand Optima
• Launch of ActivHeal AquaFiber® wound dressing